Outlook Therapeutics (41O.STU) Q1 2026 Earnings

17FebConfirmed
Q1 2026
-0.19
-0.19
-0.19
-0.19

Details

Expected EPS
-0.19122081454
Actual EPS
-0.18559640000000002
Surprise EPS
0.01
Surprise Percent
+2.94%

Description

Outlook Therapeutics (41O.STU) has reported earnings of -0.18559640000000002 per share for Q1 2026.

0 Comments

Share your thoughts